神经退行性疾病中的Glia
Gerard Crowley1, David Attwell2, Hemali Phatnani3,4
1UK Dementia Research Institute, Institute of Neurology, University College London, London W1T 7NF, United Kingdom.
Cold Spring Harbor perspectives in biology
|September 16, 2024
概括
关于神经退行症的传统神经元集中观点是不完整的. 新兴研究表明,对于大脑健康至关重要的质细胞在神经退行性疾病中起着积极的作用,特别是在老化过程中.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 衰老研究研究 衰老研究
背景情况:
- 目前普遍存在的神经退行神经中心模型不足以解释疾病机制.
- 非神经元细胞,特别是质细胞,越来越多地被认为在神经退行中发挥着积极的作用.
- 质功能对整个生命中神经元平衡至关重要,并且随着年龄的增长变得更加重要.
研究的目的:
- 审查关于质细胞在神经退行症中的作用的新兴概念.
- 突出质细胞在神经元功能障碍中超越旁观者角色的重要性.
- 讨论神经退行症的不断发展的理解,包括质贡献.
主要方法:
- 对患者群体遗传研究的审查.
- 在动物模型中分析机械和功能研究.
- 对神经退行症中的质细胞进行当前研究的综合.
主要成果:
- 证据表明,在神经退行过程中,质细胞是关键角色,而不仅仅是被动的旁观者.
- 质细胞积极调节神经元功能和平衡.
- 在衰老和神经退行过程中,质细胞的作用变得越来越重要.
结论:
- 对神经退行症的全面理解需要超越纯粹的神经中心视角.
- 膠質是神經退行性疾病病原體的重要貢獻者.
- 未来的研究应该集中在维持神经元健康和疾病状态中的质细胞的多面性作用上.
相关概念视频
Glial Cells
86.6K
Overview
86.6K
Nervous Tissue: Glial Cells
2.8K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
2.8K
Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170


